Autism spectrum disorder (ASD) affects millions of people worldwide and can influence the way someone communicates, processes information and interacts with others. Because autism presents differently in every individual, finding effective treatment options remains challenging. While there is currently no cure for autism, researchers continue to investigate therapies that may help support certain symptoms and improve quality of life.
One area that has attracted growing scientific interest is cannabidiol, better known as CBD. Extracted from the hemp plant, CBD is a non-intoxicating cannabinoid that has been studied for its interaction with the body's endocannabinoid system. Although research into CBD and autism is still developing, early findings suggest it may have the potential to support certain autism-related symptoms in some individuals.
What is autism spectrum disorder?
Autism spectrum disorder is a neurodevelopmental condition that usually becomes apparent during early childhood. The word "spectrum" reflects the wide variation in symptoms and severity. Some individuals require lifelong support, while others live independently with relatively mild challenges.
Researchers believe autism develops through a complex interaction between genetic and environmental factors. Although no single cause has been identified, genetics appear to play an important role. Environmental influences during pregnancy, such as certain infections or complications, are also being investigated as possible contributing factors.
Common characteristics of ASD include:
-
Difficulties with social communication and interaction.
-
Repetitive behaviours or routines.
-
Restricted interests.
-
Increased sensitivity to sounds, light, smells or touch.
-
Challenges adapting to change.
Some individuals with autism also experience anxiety, sleep disturbances or epilepsy. In fact, epilepsy occurs considerably more often in people with ASD than in the general population.
Why is autism so difficult to treat?
Because autism affects every person differently, there is no single treatment that works for everyone. Current approaches often combine behavioural therapy, educational support and, where appropriate, medication to manage specific symptoms such as anxiety, aggression or seizures.
Researchers continue to search for additional ways to support people with autism. One promising area focuses on understanding how communication between brain cells differs in individuals with ASD.
Brain signalling and autism
Several studies suggest that some autism-related symptoms may be linked to an imbalance between excitatory and inhibitory signals in the brain. Normally, these signals remain carefully balanced, allowing the brain to process information efficiently.
When inhibitory signalling is reduced, the brain may become overstimulated. This may contribute to sensory overload, making everyday experiences such as loud sounds, bright lights or physical contact feel overwhelming.
Scientists have therefore become interested in treatments that may help restore this balance.
In experimental research conducted at Stanford University, researchers successfully increased inhibitory signalling in mice displaying autism-like behaviour. Although this technique relied on advanced laboratory methods that cannot currently be applied in humans, it highlighted the importance of balanced brain activity in autism research.
Why are researchers studying CBD?
CBD has attracted considerable scientific attention because it interacts with the endocannabinoid system (ECS), a complex signalling network involved in maintaining balance throughout the body.
The ECS plays a role in regulating numerous biological processes, including:
-
Mood.
-
Stress responses.
-
Sleep.
-
Memory.
-
Immune function.
-
Communication between nerve cells.
Unlike THC, CBD does not produce a psychoactive "high". Instead, researchers believe it may influence several receptors involved in maintaining neurological balance.
This has led scientists to investigate whether CBD may also influence some of the biological mechanisms associated with autism.
What does the research say?
One of the most frequently cited studies was published by researchers at the University of Washington using a mouse model of Dravet syndrome. Dravet syndrome is a rare form of epilepsy that often presents with autism-like behaviours.
The researchers observed that untreated mice showed reduced social interaction, often avoiding contact with other mice. After receiving relatively low doses of CBD, these animals spent significantly more time engaging socially.
The researchers also measured electrical activity within the brain. Their findings suggested that CBD may influence communication between neurons by interacting with the GPR55 receptor, potentially helping restore a healthier balance between excitatory and inhibitory signalling.
These findings provide valuable insight into how CBD may work, but it is important to remember that animal studies cannot predict human outcomes with certainty.
What do human studies show?
While animal studies provide an important starting point, human research is still relatively limited.
Several small observational studies and clinical trials have reported improvements in behavioural symptoms, anxiety, sleep quality and irritability in some children and adolescents receiving cannabinoid-based treatments. However, many of these studies used formulations containing both CBD and small amounts of THC, making it difficult to determine the specific contribution of CBD alone.
In addition, study designs, treatment durations and dosages vary considerably between studies. As a result, researchers agree that larger, placebo-controlled clinical trials are necessary before clear conclusions can be drawn.
CBD is not a cure for autism
Although the available research is encouraging, CBD should not be viewed as a treatment or cure for autism spectrum disorder.
Current evidence suggests that CBD may offer supportive benefits for certain symptoms in some individuals, but responses vary greatly from person to person. More importantly, researchers have not yet established the optimal dosage, long-term safety or effectiveness across different age groups.
Parents or caregivers considering CBD should always discuss this with a qualified healthcare professional, particularly when epilepsy medication or other prescription medicines are involved.
Choosing a high-quality CBD oil
If you decide to explore CBD as part of your wellness routine, product quality matters. A reliable CBD oil should be produced from organically grown hemp, independently laboratory tested and clearly labelled for cannabinoid content.
Full-spectrum CBD oils contain a range of naturally occurring cannabinoids and terpenes that may work together through what researchers describe as the entourage effect. Many users prefer this type of extract because it preserves the plant's natural composition.
Ongoing research offers promising insights
Interest in cannabinoids continues to grow as scientists learn more about the endocannabinoid system and its role in neurological health. Although CBD cannot currently be recommended as a treatment for autism itself, the existing scientific evidence provides a valuable foundation for future research.
As our understanding continues to evolve, larger clinical studies will help determine whether CBD may eventually become a supportive option for certain autism-related symptoms.
"Scientific research continues to expand our understanding of CBD. While the evidence is promising, careful interpretation and well-designed clinical studies remain essential before definitive conclusions can be made."
References
-
Kaplan JS, Stella N, Catterall WA, Westenbroek RE. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proceedings of the National Academy of Sciences. 2017. https://doi.org/10.1073/pnas.1711351114
-
Aran A, Cassuto H, Lubotzky A, Wattad N, Hazan E. Cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems: A retrospective feasibility study. Journal of Autism and Developmental Disorders. 2019. https://pubmed.ncbi.nlm.nih.gov/30382443/
-
Lord C, Brugha TS, Charman T, et al. Autism spectrum disorder. Nature Reviews Disease Primers. 2020. https://www.nature.com/articles/s41572-019-0138-4
-
National Institute of Neurological Disorders and Stroke. Autism Spectrum Disorder. https://www.ninds.nih.gov/health-information/disorders/autism-spectrum-disorder
